Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,097Revenue (TTM) $M1,432Net Margin (%)24.8Altman Z-Score2.0
Enterprise Value $M8,043EPS (TTM) $5.7Operating Margin %37.2Piotroski F-Score7
P/E(ttm)17.9Beneish M-Score-2.3Pre-tax Margin (%)33.4Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %--Quick Ratio3.1Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %36.9Current Ratio3.2Lower Leverage y-yN
Price/Free Cash Flow18.5y-y EBITDA Growth Rate %0.6ROA % (ttm)9.5Higher Current Ratio y-yN
Dividend Yield %--PEG0.5ROE % (ttm)21.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M59.9ROIC % (ttm)18.0Gross Margin Increase y-yY

Gurus Latest Trades with JAZZ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JAZZJoel Greenblatt 2016-09-30 Add0.07%$118.12 - $152.82
($134.79)
$ 101.80-24%Add 45.39%153,251
JAZZGeorge Soros 2016-09-30 Sold Out -0.03%$118.12 - $152.82
($134.79)
$ 101.80-24%Sold Out0
JAZZKen Fisher 2016-09-30 Add$118.12 - $152.82
($134.79)
$ 101.80-24%Add 7.91%2,006
JAZZJoel Greenblatt 2016-06-30 Reduce-0.14%$130.55 - $157.16
($147.16)
$ 101.80-31%Reduce -46.66%105,404
JAZZGeorge Soros 2016-06-30 Buy 0.03%$130.55 - $157.16
($147.16)
$ 101.80-31%New holding7,800
JAZZKen Fisher 2016-06-30 Reduce$130.55 - $157.16
($147.16)
$ 101.80-31%Reduce -4.62%1,859
JAZZJoel Greenblatt 2016-03-31 Add0.02%$112.72 - $140.56
($124.56)
$ 101.80-18%Add 6.84%197,619
JAZZGeorge Soros 2016-03-31 Sold Out -0.01%$112.72 - $140.56
($124.56)
$ 101.80-18%Sold Out0
JAZZKen Fisher 2016-03-31 Add$112.72 - $140.56
($124.56)
$ 101.80-18%Add 4.84%1,949
JAZZNWQ Managers 2015-12-31 Sold Out -0.25%$121.94 - $150.45
($138.92)
$ 101.80-27%Sold Out0
JAZZJoel Greenblatt 2015-12-31 Add0.24%$121.94 - $150.45
($138.92)
$ 101.80-27%Add 620.48%184,961
JAZZGeorge Soros 2015-12-31 Buy 0.01%$121.94 - $150.45
($138.92)
$ 101.80-27%New holding3,200
JAZZKen Fisher 2015-12-31 Add$121.94 - $150.45
($138.67)
$ 101.80-27%Add 7.77%1,859
JAZZJoel Greenblatt 2015-09-30 Add0.03%$124.46 - $193.02
($172.53)
$ 101.80-41%Add 620.11%25,672
JAZZNWQ Managers 2015-09-30 Reduce-0.01%$124.46 - $193.02
($172.53)
$ 101.80-41%Reduce -2.34%123,720
JAZZKen Fisher 2015-09-30 Add$124.46 - $193.02
($172.53)
$ 101.80-41%Add 32.69%1,725
JAZZSteve Mandel 2015-06-30 Sold Out -0.17%$167.87 - $189.92
($179.49)
$ 101.80-43%Sold Out0
JAZZNWQ Managers 2015-06-30 Add0.15%$167.87 - $189.92
($179.49)
$ 101.80-43%Add 95.42%126,680
JAZZJoel Greenblatt 2015-06-30 Reduce-0.01%$167.87 - $189.92
($179.49)
$ 101.80-43%Reduce -67.22%3,565
JAZZSteve Mandel 2015-03-31 Reduce-1.12%$158.12 - $189.01
($171.62)
$ 101.80-41%Reduce -86.14%260,985
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JAZZ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JAZZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ENRIGHT PATRICK GDirector 2016-12-02Sell677$101.80view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-11-15Sell200$112.19-9.26view
O'Keefe Kenneth WDirector 2016-11-14Buy2,000$113.84-10.58view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-10-17Sell200$118.16-13.85view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-09-19Sell200$126.17-19.32view
Mulligan SeamusDirector 2016-08-25Sell27,968$128.32-20.67view
Treacy PaulSVP, Technical Operations 2016-08-16Sell1,292$137.47-25.95view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-08-15Sell100$136.45-25.39view
Winningham Rick EDirector 2016-08-15Sell633$136.45-25.39view
Sohn Catherine A.Director 2016-08-15Sell633$136.45-25.39view

Quarterly/Annual Reports about JAZZ:

News about JAZZ:

Articles On GuruFocus.com
U.S. Elections: What They Might Mean for Investors - JOHCM Commentary Nov 29 2016 
Gurus Invest in Undervalued Biotech Stocks Nov 25 2016 
5 Attractive Biotechnology Stocks for Healthy Long-term Returns Jun 10 2016 
Stocks Fisher Investments Has Bought for Past 2 Quarters May 03 2016 
Citigroup, Amgen Are Trading With Wide Margin of Safety Mar 30 2016 
Weekly Insider Sells Highlight: MHK, JAZZ, BMY, ZAYO Mar 23 2015 
Pharmaceutical Giant Merck Buys Cubist Pharma Dec 09 2014 
Growth Momentum Should Continue For This Pharmaceutical Company Nov 15 2014 
Jazz Pharmaceuticals: Growth Trajectory Can Continue In Future Sep 03 2014 
Weekly CFO Sells Highlight: Google Inc, Jazz Pharmaceuticals PLC, Jack in the Box Inc. Jun 30 2014 

More From Other Websites
Hedge Funds Aren’t Letting Their Money Stay At Wyndham Worldwide Corporation (WYN) Dec 07 2016
Hedge Funds Are Dumping Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ) Dec 07 2016
ETFs with exposure to Jazz Pharmaceuticals Plc : December 5, 2016 Dec 05 2016
Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial Nov 29 2016
Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Study of JZP-110... Nov 28 2016
Gurus Invest in Undervalued Biotech Stocks Nov 25 2016
JAZZ PHARMACEUTICALS PLC Financials Nov 17 2016
Blog Coverage Gilead Sciences Hepatitis B Drug Vemlidy Approved by European Medicines Agency Nov 14 2016
Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences Nov 10 2016
Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences Nov 10 2016
ETF’s with exposure to Jazz Pharmaceuticals Plc : November 10, 2016 Nov 10 2016
Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016 Nov 09 2016
The Market In 5 Minutes: Trump Victory Spooks Stocks Nov 09 2016
Jazz Pharma (JAZZ) Q3 Earnings Top, Sales Lag Estimates Nov 09 2016
Edited Transcript of JAZZ earnings conference call or presentation 8-Nov-16 9:30pm GMT Nov 09 2016
Jazz Pharmaceuticals Stock Retreats as Q3 Falls Short Nov 08 2016
Jazz Pharmaceuticals PLC Earnings Call scheduled for 4:30 pm ET today Nov 08 2016
Jazz Pharmaceuticals Announces Third Quarter 2016 Financial Results Nov 08 2016
Jazz misses Street 3Q forecasts Nov 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)